NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

COVID-19

Expand for resources

Detailed information for selected cell line:

Cell Line:	KCL043; Cystic Fibrosis mutations
NIH Registration Number:	0243
NIH Approval Number:	NIHhESC-13-0243
Available for Distribution:	Yes
Provider Restrictions:	The cells cannot be used for treatment purpose, this line carries mutations associated with Cystic Fibrosis.
Additional Information:	This line carries mutations associated with Cystic Fibrosis.
NIH Restrictions:	(No Additional Restrictions)
Submitting Organization:	King's College London
Provider Name:	Dusko Ilic, King's College London
Provider Phone:	+44 20 7188 0547
Provider Email:	dusko.ilic@kcl.ac.uk
Provider URL:	http://www.kcl.ac.uk/medicine/research/divisions/wh/about/people/illicd/index.aspx
Approval Date:	12/23/2013

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

hESC Line Listings:

NIH Form 2890:

Login Page
(Authorization Required)

Stem Cell Information:

NIH Stem Cell Information Page

RSS Feed:

RSS Data Feed

Contact Us:

Email questions to:
hescregistry@mail.nih.gov